Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing the single result
Showing the single result
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Solving the Problem of Points with a Recursion
1 × $25.00 Alternative methods of appraising the destruction of earning power
1 × $25.00 Subtotal: $50.00